Home/Elumn8 Medical/Douglas Rowe
DR

Douglas Rowe

VP, Research & Development

Elumn8 Medical

Elumn8 Medical Pipeline

DrugIndicationPhase
Acolyte™ SystemCoronary Chronic Total Occlusions (CTO)Pre-clinical